Search

In this scoping review, covering publications from January 2000 to June 2025, probable or certain transmission cases of arbovirus through substances of human origin SoHO were identified for WNV, DENV and Zika virus.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 - 7 August 2026, and includes updates on Ebola, chikungunya, dengue, West Nile Virus infection, Crimean-Congo haemorrhagic fever, Vibrio, respiratory virus epidemiology in the EU/EEA, World Pride, Middle East respiratory syndrome coronavirus, and expert deployments.

This EQA was organised within the IBDLabNet framework on behalf of ECDC to assess current EU/EEA laboratory capacity for the detection and characterisation of S. pneumoniae in both non-culture and culture-based settings.

This external quality assessment was organised within the IBDLabNet framework to assess current EU/EEA laboratory capacity for the diagnosis and characterisation of N. meningitidis in both non-culture and culture-based settings, and to identify areas requiring further harmonisation or technical support.

This external quality assessment (EQA) was organised within the IBDLabNet framework on behalf of the ECDC to assess current EU/EEA laboratory capacity for the detection and characterisation of H. influenzae in both non-culture and culture-based settings.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 - 31 July 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, dengue, avian influenza A(H9N2), expert deployment, cholera, chikungunya virus disease, Vibrio, World Pride, and an overview of respiratory virus epidemiology in the EU/EEA.

This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).

In 2024, 73 tetanus cases were reported in the EU/EEA 15 of which (21%) were confirmed cases.

The 2025 Euro-GASP EQA scheme results confirm that participating laboratories continue to demonstrate a high level of competency in the recovery and susceptibility testing of N. gonorrhoeae. With 27 countries participating and universal adherence to EUCAST guidelines, the network shows strong methodological consistency.

Transmission of hepatitis B virus (HBV) from a mother to a child (also referred to as vertical transmission), is low in EU/EEA countries, with few cases attributed to this route among acute notifications.

This report provides an overview of progress toward the interim targets for elimination for 2025 included in the WHO’s European Regional Action Plan.

For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.

In 2024, 28 540 cases of hepatitis C were reported in 29 EU/EEA countries, corresponding to a crude rate of 7.1 cases per 100 000 population.

This survey report describes the testing requirements for Hepatitis C virus in different EU/EEA countries.

This survey report aims to describe the testing requirements for hepatis B virus in different EU/EEA countries.